Archive · 23 Sep 2026
Delhi Seizes Counterfeit Abhayrab Vaccine Supply Traced to Kanpur
Officials in Delhi found fake rabies vaccine at a firm in Bhagirath Palace.
The vaccine was called Abhayrab.
The supply was traced to a supplier in Kanpur.
Officials seized 481 units during raids at three locations.
The seized vaccine was valued at about Rs 2 lakh.
Human Biologicals Institute said the batch was not made or released by the company.
Indian Immunologicals Limited said its vaccine batches are tested by the government before release.
It also said vaccines sold through authorised hospitals and licensed pharmacies are not affected.
The Delhi Drugs Control Department seized counterfeit Abhayrab rabies vaccine from a firm in Central Delhi’s Bhagirath Palace.
The supply was traced to a supplier in Kanpur, according to a government release.
Raids at three premises resulted in the seizure of 481 vaccine units valued at about Rs 2 lakh.
Human Biologicals Institute said the batch was counterfeit and had not been released by the company.
Indian Immunologicals Limited said all Abhayrab batches undergo independent government testing and authorised supplies remain unaffected.
- Who
- The Delhi Drugs Control Department, directed by Delhi Health Minister Pankaj Kumar Singh, seized the vaccine; Human Biologicals Institute and Indian Immunologicals Limited identified it as counterfeit.
- What
- Authorities seized counterfeit Purified Vero Cell Rabies Vaccine, marketed as Abhayrab, and traced its supply to Kanpur.
- When
- The seizure was reported in a government release on Monday.
- Where
- The vaccine was seized from a firm in Bhagirath Palace, Central Delhi, with the supply traced to Kanpur.
- Why
- Authorities conducted raids after identifying the vaccine as counterfeit; the raids were ordered by Delhi Health Minister Pankaj Kumar Singh.
- Product
- Purified Vero Cell Rabies Vaccine, branded Abhayrab
- Quantity seized
- 481 units, although the headline describes 418 units
- Estimated value
- Approximately Rs 2 lakh
- Seizure location
- Bhagirath Palace, Central Delhi
- Supply origin
- A supplier in Kanpur
- Manufacturer’s finding
- Human Biologicals Institute said the batch was counterfeit and had not been released by the company
- Safety assurance
- Indian Immunologicals Limited said authorised supplies remain unaffected